Bazylak et al., 2003 - Google Patents
Simultaneous high-throughput determination of clenbuterol, ambroxol and bromhexine in pharmaceutical formulations by HPLC with potentiometric detectionBazylak et al., 2003
View PDF- Document ID
- 13287844034261405101
- Author
- Bazylak G
- Nagels L
- Publication year
- Publication venue
- Journal of Pharmaceutical and Biomedical analysis
External Links
Snippet
Potentiometric detection of clenbuterol, ambroxol and bromhexine in marketed pharmaceuticals was described in six isocratic HPLC systems. The podant-and macrocyclic- type neutral ionophores, N, N, N′, N′-tetracyclohexyl-oxybis (o-phenyleneoxy) …
- 238000001514 detection method 0 title abstract description 64
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8665—Signal analysis for calibrating the measuring apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- G01N30/94—Development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bazylak et al. | Simultaneous high-throughput determination of clenbuterol, ambroxol and bromhexine in pharmaceutical formulations by HPLC with potentiometric detection | |
| Mirza et al. | Determination of captopril in pharmaceutical tablets by anion-exchange HPLC using indirect photometric detection; a study in systematic method development | |
| Almeida et al. | Determination of steroid sex hormones in real matrices by bar adsorptive microextraction (BAμE) | |
| D’Orazio et al. | Use of vancomycin chiral stationary phase for the enantiomeric resolution of basic and acidic compounds by nano-liquid chromatography | |
| Eom et al. | Rapid chiral separation of racemic cetirizine in human plasma using subcritical fluid chromatography-tandem mass spectrometry | |
| Higashi et al. | Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre‐column derivatization and fluorescence detection for pharmacokinetic studies | |
| Pinto et al. | Development and validation of a stability‐indicating HPLC method for topiramate using a mixed‐mode column and charged aerosol detector | |
| Amer et al. | Simultaneous determination of phenylephrine hydrochloride, guaifenesin, and chlorpheniramine maleate in cough syrup by gradient liquid chromatography | |
| Tsvetkova et al. | HPLC DETERMINATION OF KETOPROFEN IN TABLET DOSAGE FORMS. | |
| Kakou et al. | Determination of L-carnitine in food supplement formulations using ion-pair chromatography with indirect conductimetric detection | |
| Wang et al. | Determination of cetylpyridinium chloride and tetracaine hydrochloride in buccal tablets by RP-HPLC | |
| CN109975435A (en) | The measuring method of isopropyl mesylate content in a kind of safinamide | |
| Krzek et al. | RP-TLC determination of S (+) and R (−) ibuprofen in drugs with the application of chiral mobile phase and UV densitometric detection | |
| Venkateshwaran et al. | HPLC Determination of Morphineondansetron and Meperidine-Ondansetron Mixtures in 0.9% Sodium Chloride Injection | |
| Tan et al. | A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities | |
| Bazylak et al. | Potentiometric detection of exogenic beta-adrenergic substances in liquid chromatography | |
| Bazylak et al. | A novel potentiometric approach for detection of beta-adrenergics and beta-adrenolytics in high-performance liquid chromatography | |
| Bazylak et al. | Potentiometric detection of N, N′-diethylaminoethanol and lysosomotropic amino alcohols in cation exchange high-performance liquid chromatography systems | |
| Bazylak et al. | Macrocycle versus podant-type neutral ionophore in potentiometric detection of mucolytic agents following separation by various HPLC modes | |
| Farooqui et al. | Analytical method development and validation of secnidazole tablets by RP-HPLC | |
| Yagen et al. | Gas chromatographic assay with pharmacokinetic applications for monitoring T-2 and HT-2 toxins in plasma | |
| Liu et al. | Quantitation of trimipramine enantiomers in human serum by enantioselective high-performance liquid chromatography and mixed-mode disc solid-phase extraction | |
| Ibrahim et al. | Polarographic determination of ciclopirox olamine in pure substance and in different pharmaceutical preparations | |
| Perez-Martinez et al. | Chromatographic determination of caffeine in pharmaceutical formulations using micellar mobile phases | |
| Qin et al. | Determination of bergenin in rat plasma by high-performance liquid chromatography |